Brief: Sedana Medical Announces PDUFA Target Action Date
31/08/2026 07:07
BRIEF-Sedana Medical Announces PDUFA Target Action Date Aug 31 (Reuters) - Sedana Medical AB (publ) SEDANA.ST:
SEDANA MEDICAL ANNOUNCES PRESCRIPTION DRUG USER FEE ACT (PDUFA) TARGET ACTION DATE FOR ITS NEW DRUG APPLICATION IN THE U.S.
U.S. FOOD AND DRUG ADMINISTRATION (FDA) ACCEPTED SEDANA MEDICAL NDA FILING ON AUGUST 19
Source text: ID:nMFNc2wNXN
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln